[go: up one dir, main page]

CL2004000545A1 - Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul - Google Patents

Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul

Info

Publication number
CL2004000545A1
CL2004000545A1 CL200400545A CL2004000545A CL2004000545A1 CL 2004000545 A1 CL2004000545 A1 CL 2004000545A1 CL 200400545 A CL200400545 A CL 200400545A CL 2004000545 A CL2004000545 A CL 2004000545A CL 2004000545 A1 CL2004000545 A1 CL 2004000545A1
Authority
CL
Chile
Prior art keywords
antagonist
profilaxis
endotheline
hypertension
pathological condition
Prior art date
Application number
CL200400545A
Other languages
English (en)
Inventor
G Mcmahon Amy E Rudolph Ellen
Original Assignee
Pharmacia Corp Sa Organizada B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp Sa Organizada B filed Critical Pharmacia Corp Sa Organizada B
Publication of CL2004000545A1 publication Critical patent/CL2004000545A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

USO DE UNA COMBINACION DE UNO O MAS ANTAGONISTAS DE RECEPTORES DE LA ALDOSTERONA Y UNO O MAS ANTAGONISTAS DE RECEPTORES DE LA ENDOTELINA Y/O INHIBIDORES DE LA ECE SELECCIONADOS DE UN GRUPO ESPECIFICO DE COMPUESTOS QUE SE DESCRIBEN EN EL PRESENTE DOCUMENTO PARA EL TRATAMIENTO TERAPEUTICO Y/O PROFILAXIS PARA UNA CONDICION DE HIPERTENSION, ENFERMEDAD CARDIOVASCULAR, DISFUNCION RENAL, EDEMA, ENFERMEDAD CEREBROVASCULAR, O CONDICION PATOLOGICA DE INSULINOPATIA.
CL200400545A 2003-03-18 2004-03-17 Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul CL2004000545A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45558003P 2003-03-18 2003-03-18

Publications (1)

Publication Number Publication Date
CL2004000545A1 true CL2004000545A1 (es) 2005-01-28

Family

ID=33030025

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200400545A CL2004000545A1 (es) 2003-03-18 2004-03-17 Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul

Country Status (4)

Country Link
US (1) US20040186083A1 (es)
CL (1) CL2004000545A1 (es)
TW (1) TW200503730A (es)
WO (1) WO2004082637A2 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0506750A (pt) * 2004-01-12 2007-05-22 Solvay Pharm Bv uso de um composto
US7232813B2 (en) 2004-01-12 2007-06-19 Solvay Pharmaceuticals B.V. Neutral endopeptidase (NEP) and human soluble endopeptidase (hSEP) inhibitors for prophylaxis and treatment of neuro-degenerative disorders
US20050288272A1 (en) * 2004-06-23 2005-12-29 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists
BRPI0518829A2 (pt) 2004-12-06 2008-12-09 Avigen Inc mÉtodo para o tratamento de dor neuropÁtica e sÍndromes associadas
WO2006085815A1 (en) * 2005-02-11 2006-08-17 Astrazeneca Ab Thiazole derivatives, their process for their preparation and their use in therapy
MY146830A (en) * 2005-02-11 2012-09-28 Novartis Ag Combination of organic compounds
CA2596922A1 (en) * 2005-02-18 2006-08-24 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders
US20070196510A1 (en) * 2006-02-17 2007-08-23 Gerber Michael J Method for treating resistant hypertension
CA2646438A1 (en) * 2006-03-13 2007-09-20 Encysive Pharmaceuticals, Inc. Methods and compositions for treatment of diastolic heart failure
US20080085313A1 (en) * 2006-05-15 2008-04-10 Given Bruce D Methods and compositions for treatment of sleep apnea
EP2029137A2 (en) * 2006-06-15 2009-03-04 Gilead Colorado, Inc. Antihypertensive therapy method
US8071596B2 (en) 2007-01-12 2011-12-06 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US8080549B2 (en) 2007-01-12 2011-12-20 Concert Pharmaceuticals, Inc. Endothelin receptor antagonists
US20080181876A1 (en) * 2007-01-30 2008-07-31 Johnson Kirk W Methods for treating acute and subchronic pain
US20080287402A1 (en) * 2007-05-03 2008-11-20 Johnson Kirk W Use of a glial attenuator to prevent amplified pain responses caused by glial priming
US20090012012A1 (en) * 2007-07-05 2009-01-08 Jerome Cantor Intratracheal administration of endothelin-suppressing agents for the treatment of respiratory disorders
EP2190433A2 (en) * 2007-08-22 2010-06-02 Gilead Colorado, Inc. Therapy for complications of diabetes
DE102011015142A1 (de) * 2011-03-17 2012-09-20 Eberhard-Karls-Universität Tübingen Universitätsklinikum Agens zur Prophylaxe und Behandlung altersassoziierter Krankheiten und Störungen sowie zur Verlängerung der Lebensdauer
WO2014028059A1 (en) * 2012-08-17 2014-02-20 Father Flanagan's Boys Home Doing Business As Boys Town National Research Hospital Rac1 inhibitors for the treatment of alport glomerular disease
US9719981B2 (en) 2012-08-17 2017-08-01 Father Flanagan's Boys' Home RAC1 inhibitors for the treatment of alport glomerular disease
KR20160003128A (ko) * 2013-04-30 2016-01-08 애브비 인코포레이티드 아트라센탄을 사용하는 지질 프로파일을 개선시키기 위한 방법
WO2017185142A1 (en) * 2016-04-29 2017-11-02 Adelaide Research & Innovation Pty Ltd Method for preventing and/or treating atrial fibrillation
PL424452A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu
US20250144095A1 (en) * 2022-02-03 2025-05-08 The Johns Hopkins University Compositions and methods for treatment of connective tissue disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559332A (en) * 1983-04-13 1985-12-17 Ciba Geigy Corporation 20-Spiroxanes and analogues having an open ring E, processes for their manufacture, and pharmaceutical preparations thereof
US5594021A (en) * 1993-05-20 1997-01-14 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
US6162927A (en) * 1994-08-19 2000-12-19 Abbott Laboratories Endothelin antagonists
RO118046B1 (ro) * 1995-06-07 2003-01-30 Gd Searle & Co Chicago Asociere farmaceutica
US5883254A (en) * 1996-11-08 1999-03-16 Hoffmann-La Roche Inc. Process for making pyrimidine derivatives
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
US6638937B2 (en) * 1998-07-06 2003-10-28 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists

Also Published As

Publication number Publication date
US20040186083A1 (en) 2004-09-23
TW200503730A (en) 2005-02-01
WO2004082637A2 (en) 2004-09-30
WO2004082637A3 (en) 2007-05-10

Similar Documents

Publication Publication Date Title
CL2004000545A1 (es) Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul
ECSP066940A (es) Antagonistas del receptor de acetilcolina muscarínico
ECSP066468A (es) Antagonistas de receptores muscarínicos de acetilcolina
UY28598A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
MXPA06014798A (es) Antagonistas del receptor de hormona para liberar gonadotropina.
TNSN07264A1 (en) Organic compounds
WO2004100871A3 (en) Combination of an aldosterone receptor antagonist and a renin inhibitor
CY2015029I1 (el) Τρικυκλικοι ανταγωνιστες υποδοχεα θρομβινης
CL2007003266A1 (es) Compuestos derivados de progesterona, antagonistas del receptor de progesterona; composicion farmaceutica; y uso para el tratamiento de endometriosis, miomas o tumores dependientes de hormonas.
CL2004000544A1 (es) Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
AR065083A1 (es) Hepcidina, antagonistas de la hepcidina y metodos de uso
PL1857457T3 (pl) Pochodna benzoimidazolu i jej zastosowanie jako antagonisty receptora AII
CY1109127T1 (el) Θεραπεια αυτοανοσης νοσου σε ασθενη με ανεπαρκη αποκριση σε αναστολεα tnf-αλφα
DK1023074T3 (da) Fremgangsmåder til behandling af psykose forbundet med glucocorticoid-relateret dysfunktion
NI200900081U (es) Anticuerpos agonistas de trkb y sus usos.
CL2004000449A1 (es) Compuestos derivados de imidazol-4-il-etinil-piridina, para tratar trastornos mediados por el receptor mglur5; procedimiento de preparacion de los compuestos; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en
ECSP056254A (es) Antagonistas de receptores muscarínicos de la acetilcolina
UY28646A1 (es) Nuevos antagonistas del receptor muscarinico m3 de acetilcolina
DK1313485T3 (da) Anvendelse af en aldosteronreceptorantagonist til forbedring af kognitiv funktion
UY28567A1 (es) Antagonistas de receptores de acetilcolina muscarinicos
CL2004001507A1 (es) Compuestos derivados de espirobenzobenzazepinas sustituidos, inhibidores de receptores de vasopresina; composicion farmaceutica; utiles en el tratamiento de hipertension, disfuncion cardiaca, insuficiencia renal, entre otras.
WO2005039637A3 (en) Combinations of an aldosterone receptor antagonist, a diuretic and an angiotensin blocker
ATE435226T1 (de) Nk1-antagonisten mit kondensiertem ring
BRPI0412255A (pt) tratamento da disfunção sexual masculina
UY28415A1 (es) Antagonistas de los receptores muscarinicos de la acetilcolina